Identification/Characterization of Changes in Microscopic Colitis
Identification and Characterization of Microbial and Immunologic Changes in Microscopic Colitis
1 other identifier
observational
330
1 country
1
Brief Summary
The goal of this study is to establish a prospective observational cohort of adult patients with microscopic colitis and collect clinical information and specimens over the course of their treatment. This information will be used in order to establish a patient registry with detailed clinical data and a specimen repository for future research as well as to specifically identify genetic and molecular characteristics associated with microscopic colitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2015
CompletedFirst Submitted
Initial submission to the registry
February 21, 2017
CompletedFirst Posted
Study publicly available on registry
February 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedSeptember 1, 2021
August 1, 2021
8.1 years
February 21, 2017
August 31, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Microbiome Analysis
Standard 16s rRNA sequencing for taxonomic identification and metagenomic profiling of the gut microbiome will be performed on stool and tissue samples.
1.5 years
Immune Response
Immune cells in blood and biopsy samples will be sorted and quantified using flow cytometry
1.5 years
Secondary Outcomes (1)
α4β7 in microscopic colitis pathogenesis
2 years
Study Arms (2)
Microscopic Colitis
Patients with confirmed microscopic colitis
Control
Patients that are not diagnosed with microscopic colitis
Eligibility Criteria
Patients with suspected or established microscopic colitis who are scheduled to receive a diagnostic colonoscopy or attend an office visit at the MGH Gastroenterology Unit will be eligible for recruitment
You may qualify if:
- Ability to give informed consent
- Ability and willingness to comply with all patient visits and study-related procedures
- Ability to understand and complete all study-related materials and questionnaires
- Patients ages 18 or older with suspected microscopic colitis
- Patients that have been previously treated for microscopic colitis that are being seen for possible relapse will also be included
You may not qualify if:
- Inability to provide informed consent
- Inability or unwillingness to comply with all patient visits and study-related procedures
- Inability to understand and complete all study-related materials and questionnaires
- Patients with a known diagnosis of Inflammatory Bowel Disease or colorectal cancer
- Patients with a known bleeding disorder, acute disease, or those that are awaiting transplantation
- Patients who have taken antibiotics in the last two weeks
- Female subjects who are pregnant or nursing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Takeda Pharmaceuticals North America, Inc.collaborator
- American College of Gastroenterologycollaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (8)
Brown WR, Tayal S. Microscopic colitis. A review. J Dig Dis. 2013 Jun;14(6):277-81. doi: 10.1111/1751-2980.12046.
PMID: 23419063BACKGROUNDChande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009 Jan;104(1):235-41; quiz 234, 242. doi: 10.1038/ajg.2008.16.
PMID: 19098875BACKGROUNDColussi D, Salari B, Stewart KO, Lauwers GY, Richter JR, Chan AT, Ricciardiello L, Khalili H. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis. Scand J Gastroenterol. 2015;50(11):1382-8. doi: 10.3109/00365521.2015.1050692. Epub 2015 May 21.
PMID: 25997458BACKGROUNDJarnerot G, Hertervig E, Granno C, Thorhallsson E, Eriksson S, Tysk C, Hansson I, Bjorknas H, Bohr J, Olesen M, Willen R, Kagevi I, Danielsson A. Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol. 2001 Sep;36(9):959-62. doi: 10.1080/003655201750305486.
PMID: 11521987BACKGROUNDKao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, Kanter MH, Wirio S, Conteas CN. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009 Jul 7;15(25):3122-7. doi: 10.3748/wjg.15.3122.
PMID: 19575491BACKGROUNDKhan MA, Brunt EM, Longo WE, Presti ME. Persistent Clostridium difficile colitis: a possible etiology for the development of collagenous colitis. Dig Dis Sci. 2000 May;45(5):998-1001. doi: 10.1023/a:1005593628991. No abstract available.
PMID: 10795766BACKGROUNDLaSala PR, Chodosh AB, Vecchio JA, Schned LM, Blaszyk H. Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol. 2005 Nov-Dec;39(10):891-3. doi: 10.1097/01.mcg.0000180634.84689.c2.
PMID: 16208113BACKGROUNDYao MD, von Rosenvinge EC, Groden C, Mannon PJ. Multiple endoscopic biopsies in research subjects: safety results from a National Institutes of Health series. Gastrointest Endosc. 2009 Apr;69(4):906-10. doi: 10.1016/j.gie.2008.05.015. Epub 2009 Jan 10.
PMID: 19136110BACKGROUND
Biospecimen
Tissue, blood, stool
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hamed Khalili, MD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine at Harvard Medical School
Study Record Dates
First Submitted
February 21, 2017
First Posted
February 24, 2017
Study Start
June 30, 2015
Primary Completion
July 31, 2023
Study Completion
January 31, 2024
Last Updated
September 1, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share
Only de-identified information may be shared with other collaborators and entities involved in generating data.